Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer

March 6, 2020
share

A journal article entitled ‘Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer –
A Subgroup Analysis of the TOSCA Randomized Clinical Trial’ was published by Fausto Petrelli MD, Roberto Labianca MD and Alberto Zaniboni MD et al. on Jama Network on February 13. You can read their findings in their article.

flex
Author:
Catie Young

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.